Stoke Therapeutics (STOK) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$24.74
+3.3% on the day
-17.3% over 12 months
52-week range $22.37 – $38.35
Share price and insider trades
STOK closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$9.7M
Insiders buying0
Insiders selling8
Stoke Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $9.7M of STOK stock on the open market.
Get emailed when insiders cluster-buy stocks like STOK
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
STOK insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $44K | 2 |
| Q3 2026 | — | 0 | $1.3M | 12 |
| Q2 2026 | — | 0 | $232K | 4 |
| Q1 2026 | — | 0 | $3.1M | 27 |
| Q4 2025 | — | 0 | $6.5M | 42 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Stoke Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $9.7M. 54 of 87 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Barry TichoChief Medical Officer | Sell Plan | 1,05119,059 held (−5%) | $26.16 | $27K | -5.4% | — |
| Oct 2SEC | Jonathan AllanGeneral Counsel | Sell Plan | 62720,598 held (−3%) | $26.33 | $17K | -6.0% | — |
| Sep 3SEC | Barry TichoChief Medical Officer | Sell Plan | 3,94521,710 held (−15%) | $30.51 | $120K | -18.9% | — |
| Sep 3SEC | Barry TichoChief Medical Officer | Sell Plan | 1,60020,110 held (−7%) | $31.06 | $50K | -20.3% | — |
| Aug 18SEC | Edward M. Md KayeDirector | Sell | 11,930125,194 held (−9%) | $32.01 | $382K | -22.7% | — |
| Aug 18SEC | Barry TichoChief Medical Officer | Sell | 4,52525,897 held (−15%) | $32.01 | $145K | -22.7% | — |
| Aug 18SEC | Jonathan AllanGeneral Counsel | Sell | 2,71621,370 held (−11%) | $32.01 | $87K | -22.7% | — |
| Aug 18SEC | Edward M. Md KayeDirector | Sell | 637124,557 held (−1%) | $32.47 | $21K | -23.8% | — |
| Aug 18SEC | Barry TichoChief Medical Officer | Sell | 24225,655 held (−1%) | $32.47 | $8K | -23.8% | — |
| Aug 18SEC | Jonathan AllanGeneral Counsel | Sell | 14521,225 held (−1%) | $32.47 | $5K | -23.8% | — |
| Aug 5SEC | Barry TichoChief Medical Officer | Sell Plan | 5,90721,691 held (−21%) | $28.95 | $171K | -14.5% | — |
| Aug 5SEC | Barry TichoChief Medical Officer | Sell Plan | 1,26920,422 held (−6%) | $29.45 | $37K | -16.0% | — |
| Jul 6SEC | Barry TichoChief Medical Officer | Sell Plan | 6,72828,098 held (−19%) | $32.62 | $219K | -24.2% | — |
| Jul 6SEC | Barry TichoChief Medical Officer | Sell Plan | 50027,598 held (−2%) | $33.27 | $17K | -25.6% | — |
| Jun 18SEC | Jonathan AllanGeneral Counsel | Sell Plan | 1,45718,086 held (−7%) | $29.95 | $44K | -17.4% | — |
| Jun 3SEC | Barry TichoChief Medical Officer | Sell Plan | 1,79534,826 held (−5%) | $30.58 | $55K | -19.1% | — |
| May 5SEC | Barry TichoChief Medical Officer | Sell Plan | 2,24336,621 held (−6%) | $32.79 | $74K | -24.6% | — |
| Apr 3SEC | Barry TichoChief Medical Officer | Sell Plan | 1,83838,864 held (−5%) | $32.66 | $60K | -24.2% | — |
| Mar 24SEC | Jonathan AllanGeneral Counsel | Sell Plan | 8,69220,144 held (−30%) | $33.64 | $292K | -26.5% | — |
| Mar 24SEC | Jonathan AllanGeneral Counsel | Sell Plan | 60119,543 held (−3%) | $34.41 | $21K | -28.1% | — |
| Mar 19SEC | Barry TichoChief Medical Officer | Sell Plan | 6,10041,384 held (−13%) | $31.28 | $191K | -20.9% | — |
| Mar 19SEC | Jonathan AllanGeneral Counsel | Sell | 4,22229,242 held (−13%) | $31.28 | $132K | -20.9% | — |
| Mar 19SEC | Barry TichoChief Medical Officer | Sell Plan | 3,57750,071 held (−7%) | $32.74 | $117K | -24.4% | — |
| Mar 19SEC | Barry TichoChief Medical Officer | Sell Plan | 2,58747,484 held (−5%) | $33.38 | $86K | -25.9% | — |
| Mar 19SEC | Jonathan AllanGeneral Counsel | Sell | 2,47635,255 held (−7%) | $32.74 | $81K | -24.4% | — |
| Mar 19SEC | Thomas LeggettCFO | Sell | 2,17310,381 held (−17%) | $31.28 | $68K | -20.9% | — |
| Mar 19SEC | Jonathan AllanGeneral Counsel | Sell | 1,79133,464 held (−5%) | $33.38 | $60K | -25.9% | — |
| Mar 19SEC | Jason HoittChief Patient Officer | Sell | 1,76210,445 held (−14%) | $31.28 | $55K | -20.9% | — |
| Mar 19SEC | Barry TichoChief Medical Officer | Sell Plan | 1,46140,702 held (−3%) | $29.99 | $44K | -17.5% | — |
| Mar 19SEC | Thomas LeggettCFO | Sell | 1,27413,476 held (−9%) | $32.74 | $42K | -24.4% | — |
| Mar 19SEC | Jason HoittChief Patient Officer | Sell | 1,03312,955 held (−7%) | $32.74 | $34K | -24.4% | — |
| Mar 19SEC | Thomas LeggettCFO | Sell | 92212,554 held (−7%) | $33.38 | $31K | -25.9% | — |
| Mar 19SEC | Jason HoittChief Patient Officer | Sell | 74812,207 held (−6%) | $33.38 | $25K | -25.9% | — |
| Mar 19SEC | Barry TichoChief Medical Officer | Sell Plan | 48340,901 held (−1%) | $31.79 | $15K | -22.2% | — |
| Mar 19SEC | Jonathan AllanGeneral Counsel | Sell | 33428,908 held (−1%) | $31.79 | $11K | -22.2% | — |
| Mar 19SEC | Thomas LeggettCFO | Sell | 17210,209 held (−2%) | $31.79 | $5K | -22.2% | — |
| Mar 19SEC | Jason HoittChief Patient Officer | Sell | 13910,306 held (−1%) | $31.79 | $4K | -22.2% | — |
| Mar 19SEC | Barry TichoChief Medical Officer | Sell Plan | 10340,798 held (−0%) | $32.85 | $3K | -24.7% | — |
| Mar 19SEC | Jonathan AllanGeneral Counsel | Sell | 7228,836 held (−0%) | $32.85 | $2K | -24.7% | — |
| Mar 19SEC | Thomas LeggettCFO | Sell | 3710,172 held (−0%) | $32.85 | $1K | -24.7% | — |
| Mar 19SEC | Jason HoittChief Patient Officer | Sell | 3010,276 held (−0%) | $32.85 | $986 | -24.7% | — |
| Mar 17SEC | Arthur A LevinDirector | Sell Plan | 6054,237 held (−12%) | $36.80 | $22K | -32.8% | — |
| Mar 12SEC | Adrian R. KrainerDirector | Sell Plan | 33,243283,302 held (−11%) | $39.74 | $1.3M | -37.7% | — |
| Mar 12SEC | Arthur TzianabosChair | Sell Plan | 4,35531,339 held (−12%) | $40.00 | $174K | -38.2% | — |
| Mar 4SEC | Adrian R. KrainerDirector | Sell Plan | 7,229316,545 held (−2%) | $39.66 | $287K | -37.6% | — |
| Dec 10SEC | Edward M. Md KayeDirector | Sell Plan | 8,27450,455 held (−14%) | $32.52 | $269K | -23.9% | — |
| Dec 10SEC | Edward M. Md KayeDirector | Sell Plan | 3,82558,729 held (−6%) | $31.44 | $120K | -21.3% | — |
| Dec 10SEC | Jonathan AllanGeneral Counsel | Sell Plan | 2,67811,831 held (−18%) | $32.61 | $87K | -24.1% | — |
| Dec 10SEC | Edward M. Md KayeDirector | Sell Plan | 1,33149,124 held (−3%) | $33.10 | $44K | -25.3% | — |
| Dec 10SEC | Jonathan AllanGeneral Counsel | Sell Plan | 1,30014,509 held (−8%) | $31.60 | $41K | -21.7% | — |
| Dec 5SEC | Edward M. Md KayeDirector | Sell Plan | 6,36764,735 held (−9%) | $31.33 | $199K | -21.0% | — |
| Dec 5SEC | Jonathan AllanGeneral Counsel | Sell Plan | 5,43718,153 held (−23%) | $31.08 | $169K | -20.4% | — |
| Dec 5SEC | Edward M. Md KayeDirector | Sell Plan | 5,22272,333 held (−7%) | $30.76 | $161K | -19.6% | — |
| Dec 5SEC | Jonathan AllanGeneral Counsel | Sell Plan | 2,34415,809 held (−13%) | $31.76 | $74K | -22.1% | — |
| Dec 5SEC | Barry TichoChief Medical Officer | Sell Plan | 1,98919,798 held (−9%) | $31.35 | $62K | -21.1% | — |
| Dec 5SEC | Barry TichoChief Medical Officer | Sell Plan | 1,67321,787 held (−7%) | $31.33 | $52K | -21.0% | — |
| Dec 5SEC | Edward M. Md KayeDirector | Sell Plan | 1,68163,054 held (−3%) | $31.15 | $52K | -20.6% | — |
| Dec 5SEC | Barry TichoChief Medical Officer | Sell Plan | 1,37323,783 held (−5%) | $30.76 | $42K | -19.6% | — |
| Dec 5SEC | Edward M. Md KayeDirector | Sell Plan | 1,23171,102 held (−2%) | $31.32 | $39K | -21.0% | — |
| Dec 5SEC | Jonathan AllanGeneral Counsel | Sell Plan | 1,00423,590 held (−4%) | $31.33 | $31K | -21.0% | — |
| Dec 5SEC | Jonathan AllanGeneral Counsel | Sell Plan | 82424,788 held (−3%) | $30.76 | $25K | -19.6% | — |
| Dec 5SEC | Edward M. Md KayeDirector | Sell Plan | 50062,554 held (−1%) | $31.85 | $16K | -22.3% | — |
| Dec 5SEC | Barry TichoChief Medical Officer | Sell Plan | 32323,460 held (−1%) | $31.32 | $10K | -21.0% | — |
| Dec 5SEC | Jonathan AllanGeneral Counsel | Sell Plan | 19424,594 held (−1%) | $31.32 | $6K | -21.0% | — |
| Dec 3SEC | Jonathan AllanGeneral Counsel | Sell | 1,39419,612 held (−7%) | $30.85 | $43K | -19.8% | — |
| Dec 3SEC | Jonathan AllanGeneral Counsel | Sell | 1,41622,772 held (−6%) | $29.56 | $42K | -16.3% | — |
| Dec 3SEC | Barry TichoChief Medical Officer | Sell | 1,22515,156 held (−7%) | $30.85 | $38K | -19.8% | — |
| Dec 3SEC | Barry TichoChief Medical Officer | Sell | 1,24417,932 held (−6%) | $29.56 | $37K | -16.3% | — |
| Dec 3SEC | Jonathan AllanGeneral Counsel | Sell | 89821,006 held (−4%) | $30.34 | $27K | -18.5% | — |
| Dec 3SEC | Jonathan AllanGeneral Counsel | Sell | 86821,904 held (−4%) | $30.14 | $26K | -17.9% | — |
| Dec 3SEC | Barry TichoChief Medical Officer | Sell | 78916,381 held (−5%) | $30.34 | $24K | -18.5% | — |
| Dec 3SEC | Barry TichoChief Medical Officer | Sell | 76217,170 held (−4%) | $30.14 | $23K | -17.9% | — |
| Dec 3SEC | Edward M. Md KayeDirector | Sell | 65151,305 held (−1%) | $30.85 | $20K | -19.8% | — |
| Dec 3SEC | Edward M. Md KayeDirector | Sell | 66152,780 held (−1%) | $29.56 | $20K | -16.3% | — |
| Dec 3SEC | Edward M. Md KayeDirector | Sell | 41951,956 held (−1%) | $30.34 | $13K | -18.5% | — |
| Dec 3SEC | Edward M. Md KayeDirector | Sell | 40552,375 held (−1%) | $30.14 | $12K | -17.9% | — |
| Nov 26SEC | Adrian R. KrainerDirector | Sell Plan | 40,472323,774 held (−11%) | $29.72 | $1.2M | -16.8% | — |
| Nov 18SEC | Adrian R. KrainerDirector | Sell Plan | 20,682364,246 held (−5%) | $27.34 | $565K | -9.5% | — |
| Nov 18SEC | Adrian R. KrainerDirector | Sell Plan | 19,790384,928 held (−5%) | $26.61 | $527K | -7.0% | — |
| Nov 5SEC | Barry TichoChief Medical Officer | Sell Plan | 3,7769,350 held (−29%) | $25.22 | $95K | -1.9% | — |
| Nov 5SEC | Barry TichoChief Medical Officer | Sell Plan | 1,4557,895 held (−16%) | $26.02 | $38K | -4.9% | — |
| Nov 5SEC | Barry TichoChief Medical Officer | Sell Plan | 6007,295 held (−8%) | $27.54 | $17K | -10.2% | — |
| Nov 5SEC | Barry TichoChief Medical Officer | Sell Plan | 1007,195 held (−1%) | $29.35 | $3K | -15.7% | — |
| Oct 10SEC | Edward M. Md KayeDirector | Sell Plan | 25,00049,124 held (−34%) | $30.00 | $750K | -17.5% | — |
| Oct 7SEC | Edward M. Md KayeDirector | Sell Plan | 42,46149,124 held (−46%) | $25.09 | $1.1M | -1.4% | — |
| Oct 7SEC | Jonathan AllanGeneral Counsel | Sell Plan | 10,00011,831 held (−46%) | $25.07 | $251K | -1.3% | — |
| Oct 3SEC | Barry TichoChief Medical Officer | Sell Plan | 5,34313,126 held (−29%) | $23.64 | $126K | +4.7% | — |
Insiders at Stoke Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Adrian R. KrainerDirector | — | $3.9M | Mar 12, 2026 | — |
| Edward M. Md KayeDirector | — | $3.2M | Aug 18, 2026 | — |
| Barry TichoChief Medical Officer | — | $2.0M | Oct 2, 2026 | — |
| Jonathan AllanGeneral Counsel | — | $1.6M | Oct 2, 2026 | — |
| Arthur TzianabosChair | — | $174K | Mar 12, 2026 | — |
| Thomas LeggettCFO | — | $147K | Mar 19, 2026 | — |
| Jason HoittChief Patient Officer | — | $119K | Mar 19, 2026 | — |
| Arthur A LevinDirector | — | $22K | Mar 17, 2026 | — |
STOK stock: common questions
Are Stoke Therapeutics, Inc. insiders buying STOK stock?
In the past 12 months, 0 insiders reported open-market purchases of STOK worth $0.
Are Stoke Therapeutics, Inc. insiders selling STOK stock?
8 insiders reported sales worth $9.7M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is STOK's 52-week range?
Over the past year STOK has traded between $22.37 and $38.35. It last closed at $24.74 on Oct 9, 2026.